Clinical Trials
73 trialsDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Boehringer Ingelheim
A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
ADJUPANET
Gustave Roussy, Cancer Campus, Grand Paris
Clinical Utility of Preoperative Thyroid GuidePx® Testing
University of Calgary
PRO-COMAND
University of Pisa
AI in Endoscopic Transsphenoidal Surgery
University College, London
ALPINE 2
Technische Universität Dresden
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
Moonlight Bio, Inc
Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors
Mayo Clinic
PRRT-PGL-PHEO
Azienda USL Reggio Emilia - IRCCS
Decision Aid Efficacy in Low Risk Thyroid Cancer
University of Maryland, Baltimore
Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
M.D. Anderson Cancer Center
REPOTHYROID-II
Radboud University Medical Center
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
Memorial Sloan Kettering Cancer Center
Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
University of Michigan Rogel Cancer Center
STRAP
National Cancer Centre, Singapore
Prospective Cohort Study of Pheochromocytoma/Paraganglioma
Peking Union Medical College Hospital
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Vanderbilt-Ingram Cancer Center
ADERADHTA2
University Hospital, Toulouse
FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
Mayo Clinic
Empirical Radioactive Iodine Therapy in DTC
Assiut University
CardioNETPOL
National Institute of Cardiology, Warsaw, Poland
DETERMINE
Cancer Research UK
FOMUTI
University Hospital, Rouen
Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
NEUK203-13
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
MHI
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
REWENEC 01
Hospices Civils de Lyon
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
West China Hospital
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
First Affiliated Hospital of Zhejiang University
Ultrasound in Predicting Difficult Intubation in Acromegaly Patients
Başakşehir Çam & Sakura City Hospital
Multimodal Deep Learning for Lymph Node Metastasis in Thyroid Cancer
West China Hospital
SMILE
GCS Ramsay Santé pour l'Enseignement et la Recherche
ETP-NET
Hospices Civils de Lyon
Study of ACC-1898 in Adult Participants With Advanced Solid Tumors
AccSalus Biosciences, Inc.
HEMODYNAMICS
Central Hospital, Nancy, France
NECTARINE
Latin American Cooperative Oncology Group
Sintilimab in Combination With Surufatinib and Temozolomide in the Advanced Neuroendocrine Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery.
Sun Yat-sen University
TATC
National Health Research Institutes, Taiwan
RET-US
Fujian Medical University
Study of ZG006 in Participants With Neuroendocrine Prostate Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma
Beijing GoBroad Hospital
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
Xijing Hospital
MAeSTro-TSH
National Cancer Center, Korea
Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors
University Medical Center Groningen
MAeSTro-SDM
National Cancer Center, Korea
A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer
Beijing GoBroad Hospital
Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma
Sun Yat-sen University
Phase I Study of HS-20108 in Participants With Advanced Solid Tumors
Hansoh BioMedical R&D Company